Your browser doesn't support javascript.
loading
Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu®) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance.
O'Shea, Leah K; Abdulkhalek, Samar; Allison, Stephanie; Neufeld, Ronald J; Szewczuk, Myron R.
Afiliação
  • O'Shea LK; Department of Biomedical and Molecular Sciences.
  • Abdulkhalek S; Department of Biomedical and Molecular Sciences.
  • Allison S; Department of Chemical Engineering, Queen's University, Kingston, ON, Canada.
  • Neufeld RJ; Department of Chemical Engineering, Queen's University, Kingston, ON, Canada.
  • Szewczuk MR; Department of Biomedical and Molecular Sciences.
Onco Targets Ther ; 7: 117-34, 2014.
Article em En | MEDLINE | ID: mdl-24470763
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2014 Tipo de documento: Article